The role of leukotoxin (9,10-epoxy-12-octadecenoate) in the genesis of coagulation abnormalities.
This study was designed to clarify whether or not leukotoxin (9, 10-epoxy-12-octadecenoate), which is biosynthesized by neutrophils, might be involved in the genesis of coagulating abnormalities. Twelve dogs were divided into 2 groups. In the test group (n = 6), 100 mumol/kg of leukotoxin was injected intravenously, and in the control group (n = 6), 100 mumol/kg of linoleate was injected. In each group, a series of blood samples were collected and used for coagulation studies. After the end of the experimental period, a histological study was performed on organs removed from the dogs. In the leukotoxin group, fibrin and fibrinogen degradation products (FDP) was increased time-dependently. Fibrinogen was decreased, and prothrombin time and activated partial thromboplastin time were prolonged in parallel with the increase in FDP. A decrease in number of platelets was also observed. Intravascular coagulation was observed in sections of lung. These data were compatible with a diagnosis of disseminated intravascular coagulation (DIC). No significant changes in these parameters were observed in the linoleate group. Leukotoxin has been confirmed to show antifungal and antibacterial activity, and its production might be a defensive response to infection. Over-production of leukotoxin associated with severe infection might therefore account for infection-induced DIC.
Sugiyama
S
S
Department of Biomedical Chemistry, Faculty of Medicine, University of Nagoya, Japan.
Hayakawa
M
M
Hanaki
Y
Y
Hieda
N
N
Asai
J
J
Ozawa
T
T
D000818:Animals; D004211:Disseminated Intravascular Coagulation / Q000097:blood* / Q000139:chemically induced / Q000473:pathology; D004285:Dogs; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism; D019787:Linoleic Acid; D008041:Linoleic Acids / Q000502:physiology / Q000633:toxicity*; D008168:Lung / Q000187:drug effects / Q000473:pathology; D008297:Male; D010314:Partial Thromboplastin Time; D010976:Platelet Count / Q000187:drug effects; D011517:Prothrombin Time; D014118:Toxins, Biological / Q000633:toxicity*
D005338:Fibrin Fibrinogen Degradation Products; D008041:Linoleic Acids; D014118:Toxins, Biological; C051208:9,10-epoxy-12-octadecenoic acid; D019787:Linoleic Acid